- NCIt
- C8101
Loading cancer entity…
Loading cancer entity…
Clinical trials
1,164 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00892385 | Methoxyamine and Temozolomide in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 66 | Case Comprehensive Cancer CenterOTHER | 1 | Feb 22, 2019 | clinicaltrials |
| NCT00547677 | Stereotactic Radiosurgery for Patients With Hepatic Metastases. | completed | Phase 1 | 27 | University of Texas Southwestern Medical CenterOTHER | 1 | Feb 15, 2019 | clinicaltrials |
| NCT00005639 | Azacitidine Plus Phenylbutyrate in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Treatment | completed | Phase 1 | 34 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Jan 11, 2019 | clinicaltrials |
| NCT01923337 | Irinotecan and Alisertib in Treating Patients With Advanced Solid Tumors or Colorectal Cancer | completed | Phase 1 | 17 | University of California, DavisOTHER | 1 | Jan 4, 2019 | clinicaltrials |
| NCT00390429 | Docetaxel and Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors | completed | Phase 1 / Phase 2 | 81 | University of California, DavisOTHER | 1 | Dec 6, 2018 | clinicaltrials |
| NCT01332721 | Study of TRC105 Combined With Standard-Dose Bevacizumab for Advanced Solid Tumors for Which Bevacizumab is Indicated | completed | Phase 1 | 38 | Tracon Pharmaceuticals Inc.INDUSTRY | 1 | Dec 5, 2018 | clinicaltrials |
| NCT00096317 | Ixabepilone and Ketoconazole in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 29 | Montefiore Medical CenterOTHER | 1 | Oct 31, 2018 | clinicaltrials |
| NCT00389805 | Bortezomib and Pemetrexed Disodium in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors | completed | Phase 1 / Phase 2 | 27 | University of California, DavisOTHER | 1 | Oct 31, 2018 | clinicaltrials |
| NCT00005807 | Treating Patients With Advanced Solid Tumors, Breast Cancer or Recurrent Ovarian Cancer(BMS-247550) | completed | Phase 1 | 40 | Albert Einstein College of MedicineOTHER | 1 | Oct 9, 2018 | clinicaltrials |
| NCT00896792 | Nurse Practitioner Hospice Program for Patients With Terminal Metastatic Cancer and Their Families or Caregivers | completed | Early Phase 1 | 26 | Mayo ClinicOTHER | 1 | Oct 9, 2018 | clinicaltrials |
| NCT00410553 | Eribulin Mesylate and Gemcitabine Hydrochloride in Treating Patients With Metastatic Solid Tumors or Solid Tumors That Cannot be Removed by Surgery | completed | Phase 1 | 45 | National Cancer Institute (NCI)NIH | 1 | Oct 3, 2018 | clinicaltrials |
| NCT00004863 | Paclitaxel and GEM 231 in Treating Patients With Recurrent or Refractory Solid Tumors | completed | Phase 1 | 18 | Montefiore Medical CenterOTHER | 1 | Sep 10, 2018 | clinicaltrials |
| NCT00004864 | Docetaxel and GEM 231 in Treating Patients With Recurrent or Refractory Solid Tumors | completed | Phase 1 | — | Montefiore Medical CenterOTHER | 1 | Sep 10, 2018 | clinicaltrials |
| NCT00003713 | Chemotherapy in Treating Patients With Advanced or Metastatic Solid Tumors | completed | Phase 1 | 35 | Genzyme, a Sanofi CompanyINDUSTRY | 2 | Aug 29, 2018 | clinicaltrials |
| NCT00003822 | SR-45023A in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 30 | Genzyme, a Sanofi CompanyINDUSTRY | 1 | Aug 29, 2018 | clinicaltrials |
| NCT00004049 | SR-45023A in Treating Patients With Locally Advanced or Metastatic Solid Tumors | completed | Phase 1 | 36 | Genzyme, a Sanofi CompanyINDUSTRY | 1 | Aug 29, 2018 | clinicaltrials |
| NCT00002943 | Carboplatin, Etoposide, Cyclophosphamide, and Autologous Bone Marrow Transplantation in Patients With Relapsed or Refractory Cancer | completed | Phase 2 | 11 | Wake Forest University Health SciencesOTHER | 1 | Aug 10, 2018 | clinicaltrials |
| NCT01015560 | S0916, MLN1202 in Treating Patients With Bone Metastases | completed | Phase 2 | 44 | SWOG Cancer Research NetworkNETWORK | 1 | Aug 9, 2018 | clinicaltrials |
| NCT01506440 | Cognitive Assessments in Patients With Cancer Undergoing Chemotherapy | completed | — | 29 | Wake Forest University Health SciencesOTHER | 1 | Jul 3, 2018 | clinicaltrials |
| NCT02166255 | APN401 in Treating Patients With Melanoma, Kidney Cancer, Pancreatic Cancer, or Other Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery | completed | Phase 1 | 17 | Wake Forest University Health SciencesOTHER | 1 | Jul 3, 2018 | clinicaltrials |
| NCT00074308 | Imatinib Mesylate and Bevacizumab in Treating Patients With Advanced Melanoma or Other Advanced Cancers | completed | Phase 1 / Phase 2 | 40 | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2018 | clinicaltrials |
| NCT00837928 | Bendamustine and Radiation Therapy in Treating Patients With Brain Metastases Caused by Solid Tumors | completed | Phase 1 | 18 | John GreculaOTHER | 1 | May 17, 2018 | clinicaltrials |
| NCT00068445 | Lamotrigine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer | completed | Phase 3 | 131 | Alliance for Clinical Trials in OncologyOTHER | 1 | May 4, 2018 | clinicaltrials |
| NCT01042535 | Vaccine Therapy and 1-MT in Treating Patients With Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 44 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Apr 11, 2018 | clinicaltrials |
| NCT00290680 | Bortezomib and Celecoxib in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 36 | Medical University of South CarolinaOTHER | 1 | Apr 10, 2018 | clinicaltrials |
| NCT00334789 | Belinostat and Isotretinoin in Treating Patients With Solid Tumors That Are Metastatic or That Cannot Be Removed by Surgery | completed | Phase 1 | 51 | National Cancer Institute (NCI)NIH | 1 | Apr 3, 2018 | clinicaltrials |
| NCT01654965 | Tivantinib and Topotecan Hydrochloride in Treating Patients With Advanced or Metastatic Solid Tumors | completed | Phase 1 | 17 | National Cancer Institute (NCI)NIH | 1 | Apr 3, 2018 | clinicaltrials |
| NCT00014261 | Temozolomide Plus PEG-Interferon Alfa-2B in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Mar 30, 2018 | clinicaltrials |
| NCT01566279 | A Study to Identify a Biomarker Predictive for Response on Everolimus in Solid Tumors (CPCT-03)(CPCT-03) | completed | N/A | 73 | UMC UtrechtOTHER | 1 | Mar 9, 2018 | clinicaltrials |
| NCT00825201 | Intraperitoneal Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Cancer of the Peritoneal Cavity | completed | Phase 1 | 27 | City of Hope Medical CenterOTHER | 1 | Jan 19, 2018 | clinicaltrials |
| NCT00033241 | Erlotinib Combined With Gemcitabine in Treating Patients With Newly Diagnosed Locally Advanced or Metastatic Pancreatic Cancer or Other Solid Tumors | completed | Phase 1 | — | OSI PharmaceuticalsINDUSTRY | 1 | Jan 10, 2018 | clinicaltrials |
| NCT00810394 | Sorafenib in Treating Patients With Advanced Malignant Solid Tumors | completed | Phase 2 | 50 | University of California, DavisOTHER | 1 | Jan 10, 2018 | clinicaltrials |
| NCT02194049 | Cisplatin, Etoposide and PI3K Inhibitor BKM120 in Treating Patients With Advanced Solid Tumors or Small Cell Lung Cancer | completed | Phase 1 | 3 | University of California, DavisOTHER | 1 | Jan 9, 2018 | clinicaltrials |
| NCT00098514 | Talotrexin in Treating Patients With Advanced or Recurrent Solid Tumors | completed | Phase 1 | 53 | Dana-Farber Cancer InstituteOTHER | 1 | Dec 18, 2017 | clinicaltrials |
| NCT00899522 | Tissue Sample Collection From Patients With Fanconi Anemia | completed | — | 8 | OHSU Knight Cancer InstituteOTHER | 1 | Dec 4, 2017 | clinicaltrials |
| NCT00622674 | Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 37 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Dec 2, 2017 | clinicaltrials |
| NCT01264432 | Veliparib and Radiation Therapy in Treating Patients With Advanced Solid Malignancies With Peritoneal Carcinomatosis, Epithelial Ovarian, Fallopian, or Primary Peritoneal Cancer | completed | Phase 1 | 34 | National Cancer Institute (NCI)NIH | 2 | Nov 21, 2017 | clinicaltrials |
| NCT00389584 | Irinotecan and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases From Solid Tumors | completed | Phase 1 / Phase 2 | 30 | University of California, DavisOTHER | 1 | Nov 6, 2017 | clinicaltrials |
| NCT00182780 | American Ginseng in Treating Patients With Cancer-Related Fatigue | completed | N/A | 290 | Alliance for Clinical Trials in OncologyOTHER | 0 | Oct 31, 2017 | clinicaltrials |
| NCT00499135 | Sunitinib Malate in Treating Patients With Unresectable or Metastatic Kidney Cancer or Other Advanced Solid Tumors | completed | Phase 1 | 25 | National Cancer Institute (NCI)NIH | 1 | Oct 10, 2017 | clinicaltrials |
| NCT01227954 | Avoiding the Hippocampus During Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases | completed | Phase 2 | 113 | Radiation Therapy Oncology GroupNETWORK | 2 | Sep 27, 2017 | clinicaltrials |
| NCT01263145 | MK2206 and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Metastatic Breast Cancer | completed | Phase 1 | 34 | National Cancer Institute (NCI)NIH | 1 | Aug 25, 2017 | clinicaltrials |
| NCT00516503 | Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer | completed | Phase 3 | 208 | Alliance for Clinical Trials in OncologyOTHER | 1 | Aug 24, 2017 | clinicaltrials |
| NCT00566852 | Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors | completed | Phase 3 | 554 | Radiation Therapy Oncology GroupNETWORK | 2 | Aug 21, 2017 | clinicaltrials |
| NCT00541359 | Bortezomib and Topotecan Hydrochloride in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 54 | City of Hope Medical CenterOTHER | 1 | Aug 9, 2017 | clinicaltrials |
| NCT00924651 | Exercise in Lessening Fatigue Caused by Cancer in Patients Undergoing Chemotherapy(EXCAP) | completed | N/A | 693 | Gary MorrowOTHER | 1 | Aug 8, 2017 | clinicaltrials |
| NCT00471562 | Angiotensin-(1-7) in Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | 18 | Wake Forest University Health SciencesOTHER | 1 | Aug 1, 2017 | clinicaltrials |
| NCT01015963 | Studying DNA in Tissue Samples From Caucasian and African-American Cancer Patients Who Received Docetaxel on Clinical Trial CLB-9871 | completed | — | 69 | Alliance for Clinical Trials in OncologyOTHER | 0 | Jul 13, 2017 | clinicaltrials |
| NCT00983359 | Stereotactic Radiation Therapy in Treating Patients With Brain Metastases | completed | N/A | 40 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Jun 6, 2017 | clinicaltrials |
| NCT00112593 | Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer | completed | N/A | 5 | Fred Hutchinson Cancer CenterOTHER | 1 | May 24, 2017 | clinicaltrials |
Data updated 23 days agoSource updated Feb 22, 2019source: clinicaltrials